Search results for "transfusion"

showing 10 items of 177 documents

Transfusion Therapy in a Multi-Ethnic Sickle Cell Population Real-World Practice. a Preliminary Data Analysis of Multicentre Survey

2018

Abstract Introduction. Despite the increasing of number of patients with Sickle Cell Disease (SCD) in Italy, due to multi-ethnic migratory phenomena, a large percentage of Caucasian sickle population is already present in Italy mainly with b-thal/HbS genotype. Red cell transfusion is one effective treatment for both acute and chronic complications of SCD, while hydroxycarbamide (HC) is used to reduce the frequency of painful vaso-occlusive crises (VOCs) and decrease the need for blood transfusion. Through the National Comprehensive Reference Centers for SCD, the Italian Society of Thalassemia and Hemoglobinopathies (SITE), in collaboration with the Society Italian Transfusion Medicine and I…

education.field_of_studyPediatricsmedicine.medical_specialtyBlood transfusionAnemiabusiness.industrymedicine.medical_treatmentImmunologyPopulationTransfusion medicineCell BiologyHematology030204 cardiovascular system & hematologymedicine.diseaseBiochemistryAcute chest syndromeSickle cell anemia03 medical and health sciencesRegimen0302 clinical medicine030220 oncology & carcinogenesismedicineTransfusion therapyeducationbusiness
researchProduct


 Donor Exposures in Recipients of Pooled Platelet Concentrates: a Case-Study in Arithmetic, Logic, "Expert Opinion", and the "Peer Review" Proc…

2013

Advocacy for single-donor (rather than pooled) platelets has been based on the absolute increase in the risk of transfusion-transmitted infections (TTIs) from pooled (rather than single-donor) platelets in the population of platelet transfusion recipients. A recent study published in a prestigious medical journal advocated for pooled (rather than single-donor) platelets based on the relative increase in the risk of TTIs from pooled (rather than single-donor) platelets in patients transfused with any blood component. If this policy recommendation for use of pooled (rather than single-donor) platelets were followed in the US, there would be an annual increase in the risk of TTIs by 15-20 reci…

education.field_of_studybusiness.industryBlood componentPopulationGeneral Biochemistry Genetics and Molecular BiologyPeer reviewPlatelet transfusionExpert opinionMedicinePlateletIn patientMedical journalArithmeticbusinesseducationClinical Laboratory
researchProduct

Análisis de la introducción del protocolo de ahorro de sangre de cirugía cardíaca en un hospital terciario

2018

Antecedentes: En la última década, todos los sistemas de salud avanzados están implantando programas de ahorro de sangre siguiendo las recomendaciones de Sociedades Europeas y Americanas que han propuesto guías clínicas para el ahorro de sangre, siguiendo un enfoque multidisciplinar y multimodal. La reducción en el consumo lleva emparejado una reducción de complicaciones asociadas a la transfusión, mejora de resultados clínicos y reducción de costes. La cirugía cardiaca es una de las especialidades quirúrgicas con mayor riesgo hemorrágico, tanto por la intervención quirúrgica en sí misma, como por la influencia farmacológica a la cual se ve sometido el paciente en el periodo perioperatorio.…

estancia hospitalariahemoderivadoscomplicacionestasa transfusionalUNESCO::CIENCIAS MÉDICAScirugía cardíacatransfusión de componentes sanguíneos:CIENCIAS MÉDICAS [UNESCO]ahorro de sangre
researchProduct

Subjective and Objective Outcomes of Ankle Joint Arthrodesis with Either Ilizarov or Internal Fixation

2021

After arthroplasty, arthrodesis of the ankle joint is the most common method to treat advanced ankle osteoarthritis. The goal of the study was to assess the subjective and objective outcomes in 2 different types of fixation for ankle joint arthrodesis. We retrospectively assessed 47 patients who had undergone ankle joint arthrodesis with fixation either via an Ilizarov apparatus (group 1) (n = 21) or cannulated screws (group 2) (n = 26). The outcomes were measured by: (1) the quantity of analgesics administered, (2) the American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score, (3) general patient satisfaction, (4) the patients' decision to undergo the same procedure given an…

external fixationsatisfactionOrthopedics and Sports MedicineSurgeryscrew fixationblood transfusionJournal of Foot & Ankle Surgery
researchProduct

Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies

2018

Daratumumab has proven to be highly efficacious for relapsed and refractory multiple myeloma (MM) and has recently been approved in the frontline setting for MM patients ineligible for transplantation. In the future, expanded indications are possible for daratumumab and other anti-CD38 monoclonal antibodies in development. For several years, it has been recognized that these therapies interfere with blood bank testing by binding to CD38 on red blood cells and causing panagglutination on the Indirect Antiglobulin Test. This can lead to redundant testing and significant delays in patient care. Given the anticipated increase in utilization of anti-CD38 monoclonal antibodies, as well as the tra…

lcsh:Immunologic diseases. Allergymedicine.medical_specialtyErythrocytesBlood transfusionmedicine.drug_classmedicine.medical_treatmentImmunologyAntineoplastic AgentsReview030204 cardiovascular system & hematologyCD38Monoclonal antibody03 medical and health sciences0302 clinical medicinemedicineHumansImmunology and AllergyBlood TransfusionDiagnostic ErrorsIntensive care medicinetransfusionIsatuximabbusiness.industryAntibodies MonoclonalDaratumumabdaratumumabADP-ribosyl Cyclase 1TransplantationCoombs TestBlood Grouping and Crossmatchingmonoclonal antibodyPractice Guidelines as TopicIndirect Antiglobulin Testlcsh:RC581-607Multiple MyelomabusinessCD38Blood bankProtein Bindingisatuximab030215 immunologyFrontiers in Immunology
researchProduct

Control Of Organ Transplant-Associated Graft-versus-Host Disease By Activated Host Lymphocyte Infusions

2004

Background Prolonged persistence of donor-derived T cells after organ transplantation has been proposed to improve long-term allograft survival. However, surviving transplant-derived T cells are also able to mediate devastating graft-versus-host disease (GvHD). Currently, GvHD after organ transplantation is usually refractory to conventional therapy and the disease outcome fatal. Methods Graft-reactive host T cells were generated ex vivo from a patient suffering from a severe and refractory liver-transplant-associated GvHD. To control GvHD, activated alloreactive host T cells were repetitively retransferred into the patient (activated host lymphocyte infusion [aHLI]). Results Adoptive trans…

medicine.medical_specialtyAdoptive cell transferLymphocytemedicine.medical_treatmentGraft vs Host Diseasechemical and pharmacologic phenomenaLymphocyte ActivationImmunotherapy AdoptiveSeverity of Illness IndexOrgan transplantationBlood Transfusion AutologousmedicineHumansAgedTransplantationbusiness.industryImmunotherapymedicine.diseaseAdoptive TransferLiver TransplantationTransplantationsurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureLymphocyte TransfusionImmunologyFemaleStem cellEpidermolysis BullosabusinessEx vivoTransplantation
researchProduct

[Compensation mechanisms of perioperative anemia].

2002

medicine.medical_specialtyAnemiabusiness.industryHemodynamicsAnemiaGeneral MedicinePerioperativeCritical Care and Intensive Care Medicinemedicine.diseaseSurgeryCompensation (engineering)OxygenHemoglobinsAnesthesiology and Pain MedicineAnesthesiaEmergency MedicinemedicineAnimalsHumansBlood TransfusionbusinessIntraoperative ComplicationsAnasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
researchProduct

<p>Preoperative Anemia Screening and Treatment Practices in Patients Having Total Joint Replacement Surgery: A Retrospective, Observational Aud…

2020

Background: Surgical patients with preoperative anemia are more likely to experience adverse outcomes. Patient blood management (PBM) guidelines recommend screening and treating patients for anemia preoperatively to enable optimisation before surgery. This study investigates compliance with PBM guidelines and reports the association between length of stay and transfusion risk in patients with preoperative anemia. Study Design and Methods: A retrospective, observational, chart audit that included all patients having primary, total hip and knee replacement surgery between July–December 2018 at a tertiary, metropolitan healthcare facility. Results: Six hundred and seven patients patients were …

medicine.medical_specialtyBlood managementBlood transfusionbusiness.industryAnemiamedicine.medical_treatmentKnee replacementRenal functionHematologyAuditOdds ratio030204 cardiovascular system & hematologymedicine.diseaseSurgery03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMedicineObservational studybusinessJournal of Blood Medicine
researchProduct

Assessing transfusion practice in elective surgical patients: a baseline audit

2019

Background Externally generated hospital benchmarking data indicated that the blood transfusion rate within elective surgical orthopaedic and gastrointestinal patients at a metropolitan, tertiary healthcare facility was higher than comparable Australian hospitals. An investigation of transfusion practices was undertaken with the aim of understanding the reasons contributing to this higher incidence. Study Methods A chart audit was undertaken of every major, elective, surgical orthopaedic and gastrointestinal patient who received a blood transfusion between July and December 2017. The audit aimed to ascertain whether patients were screened and treated for preoperative anaemia and measure the…

medicine.medical_specialtyBlood managementBlood transfusionbusiness.industryIncidence (epidemiology)medicine.medical_treatmentPsychological interventionAuditPerioperative030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineVDP::Medisinske Fag: 700::Helsefag: 800Emergency medicinemedicineGeneral Earth and Planetary SciencesDecompensationbusiness030215 immunologyGeneral Environmental ScienceSurgical patients
researchProduct

The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status.

2016

Background The prognostic role of perioperative blood transfusion (PBT) in patients who underwent radical cystectomy (RC) for bladder cancer (BCa), although supported by clinical evidence, still remains to be assessed definitively. Objective To investigate the impact of PBT on RC patients for overall survival and after stratifying according to preoperative anemia status and to define whether the oncologic impact may be assumed to be a primary effect of PBT or attributed to the reduced preoperative hemoglobin (Hb) level. Design, setting, and participants A total of 1490 consecutive patients with nonmetastatic BCa who underwent RC and pelvic lymph node dissection between January 1990 and Augu…

medicine.medical_specialtyBlood transfusionAnemiaUrologymedicine.medical_treatmentPopulation030232 urology & nephrologyUrologySettore MED/24 - UrologiaCystectomy03 medical and health sciences0302 clinical medicinemedicineHemoglobineducationeducation.field_of_studyBladder cancerProportional hazards modelbusiness.industryTransfusionBladder cancerHazard ratioPerioperativemedicine.diseaseSurgeryRadical cystectomy030220 oncology & carcinogenesisbusinessPredictorEuropean urology focus
researchProduct